Free Trial

23andMe (ME) News Today

23andMe logo
$0.50 -0.27 (-35.32%)
Closing price 03/28/2025
Extended Trading
$0.50 0.00 (0.00%)
As of 03/28/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ME Latest News

This March 25, 2025 photo shows a 23andMe saliva collection kit in Oakland, Calif
Biotechnology company Regeneron buying 23andMe for $256 million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection
Get 23andMe News Delivered to You Automatically

Sign up to receive the latest news and ratings for ME and its competitors with MarketBeat's FREE daily newsletter.

Related Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
Buy the Fear: 3 Down Stocks That Could 10x Your Profits

ME Media Mentions By Week

ME Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ME
News Sentiment

0.16

1.03

Average
Medical
News Sentiment

ME News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ME Articles
This Week

12

8

ME Articles
Average Week

Get 23andMe News Delivered to You Automatically

Sign up to receive the latest news and ratings for ME and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ME) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners